Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 20; no. 1; pp. 274 - 281
Main Author Mikulski, S. M.
Format Journal Article
LanguageEnglish
Published American Society of Clinical Oncology 01.01.2002
Online AccessGet full text

Cover

More Information
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.20.1.274